ICLR.US ICON PLC

Healthcare Life Sciences Tools & Services USA Stocks
194.65 USD
Close of Nov 15, 2026
66.57 219.04
Market cap
USD 14.6B
P/E
77.9x
P/B
1.60x
ROE
4.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is ICLR.US undervalued?

Graham number
Price194.65
Graham value82.78
Premium135.1%

ICLR.US trades 135.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ICON PLC fundamental analysis

No fundamental analysis for ICON PLC yet.

ICON PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ICON PLC

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of developmen…

Full company profile